Targeting the interleukin-7 receptor alpha by an anti-CD127 monoclonal antibody improves allergic airway inflammation in mice.

Hoa Le MaiThi Van Ha NguyenGrégory BouchaudKelly HenrioMarie-Aude CheminantAntoine MagnanSophie Brouard

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2020)

Targeting the IL-7Rα by an anti-CD127 mAb improves allergic airway inflammation in mice and presents as a potential therapeutic approach for allergic asthma.

Keyphrases

monoclonal antibody
allergic rhinitis
high fat diet induced
cancer therapy
chronic obstructive pulmonary disease
atopic dermatitis
lung function
type diabetes
drug delivery
insulin resistance
wild type